Spectris (SXS) Competitors

GBX 3,274
+20.00 (+0.61%)
(As of 04/26/2024 ET)

SXS vs. RSW, SCT, DARK, CCC, FBT, NETW, OXIG, BYIT, KNOS, and SPT

Should you be buying Spectris stock or one of its competitors? The main competitors of Spectris include Renishaw (RSW), Softcat (SCT), Darktrace (DARK), Computacenter (CCC), First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT), Network International (NETW), Oxford Instruments (OXIG), Bytes Technology Group (BYIT), Kainos Group (KNOS), and Spirent Communications (SPT). These companies are all part of the "computer and technology" sector.

Spectris vs.

Spectris (LON:SXS) and Renishaw (LON:RSW) are both mid-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.

In the previous week, Renishaw had 1 more articles in the media than Spectris. MarketBeat recorded 1 mentions for Renishaw and 0 mentions for Spectris. Spectris' average media sentiment score of 0.00 beat Renishaw's score of -0.38 indicating that Spectris is being referred to more favorably in the media.

Company Overall Sentiment
Spectris Neutral
Renishaw Neutral

Spectris received 303 more outperform votes than Renishaw when rated by MarketBeat users. Likewise, 64.96% of users gave Spectris an outperform vote while only 55.19% of users gave Renishaw an outperform vote.

CompanyUnderperformOutperform
SpectrisOutperform Votes
521
64.96%
Underperform Votes
281
35.04%
RenishawOutperform Votes
218
55.19%
Underperform Votes
177
44.81%

Spectris has higher revenue and earnings than Renishaw. Spectris is trading at a lower price-to-earnings ratio than Renishaw, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectris£1.45B2.27£145.40M£1.402,338.57
Renishaw£671.38M4.55£97.21M£1.343,130.60

Spectris has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Renishaw has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Spectris pays an annual dividend of GBX 79 per share and has a dividend yield of 2.4%. Renishaw pays an annual dividend of GBX 76 per share and has a dividend yield of 1.8%. Spectris pays out 5,642.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Renishaw pays out 5,671.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Spectris is clearly the better dividend stock, given its higher yield and lower payout ratio.

Renishaw has a net margin of 14.48% compared to Spectris' net margin of 10.03%. Renishaw's return on equity of 11.31% beat Spectris' return on equity.

Company Net Margins Return on Equity Return on Assets
Spectris10.03% 10.56% 6.72%
Renishaw 14.48%11.31%7.17%

Spectris presently has a consensus target price of GBX 6,444, indicating a potential upside of 96.82%. Renishaw has a consensus target price of GBX 3,360, indicating a potential downside of 19.90%. Given Spectris' stronger consensus rating and higher possible upside, equities research analysts clearly believe Spectris is more favorable than Renishaw.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectris
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Renishaw
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

83.8% of Spectris shares are owned by institutional investors. Comparatively, 43.5% of Renishaw shares are owned by institutional investors. 1.3% of Spectris shares are owned by company insiders. Comparatively, 53.3% of Renishaw shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Spectris beats Renishaw on 12 of the 20 factors compared between the two stocks.

Get Spectris News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXS vs. The Competition

MetricSpectrisScientific & Technical Instruments IndustryComputer SectorLON Exchange
Market Cap£3.30B£463.15M£19.85B£1.55B
Dividend Yield2.42%3.80%2.77%11.73%
P/E Ratio2,338.57719.81227.291,825.55
Price / Sales2.271,426.66529.33340,113.01
Price / Cash28.5117.4228.1527.80
Price / Book2.562.916.692.61
Net Income£145.40M£15.92M£635.62M£175.61M
7 Day Performance3.02%0.15%2.91%1.40%
1 Month Performance-0.03%-0.88%-2.86%4.12%
1 Year Performance-12.48%12.17%16.75%13.84%

Spectris Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RSW
Renishaw
0.0515 of 5 stars
GBX 4,100
+1.9%
GBX 3,360
-18.0%
+17.2%£2.98B£671.38M3,059.705,166News Coverage
SCT
Softcat
0.5982 of 5 stars
GBX 1,600
+2.5%
GBX 1,393.33
-12.9%
+18.0%£3.20B£940.05M2,857.142,315Positive News
DARK
Darktrace
0.2331 of 5 stars
GBX 490
+2.0%
GBX 575
+17.3%
+121.7%£3.43B£616.47M3,769.232,300News Coverage
Gap Down
CCC
Computacenter
2.5743 of 5 stars
GBX 2,574
+0.6%
GBX 3,625
+40.8%
+12.2%£2.94B£6.92B1,487.8621,135
FBT
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
0 of 5 stars
GBX 1,428.20
+1.7%
N/A-4.9%£4.22B£870,310.00-1,298.3620
NETW
Network International
0 of 5 stars
GBX 394
-0.1%
N/A+1.9%£2.10B£472.63M3,283.332,133
OXIG
Oxford Instruments
0.5036 of 5 stars
GBX 2,125
+2.7%
GBX 2,281
+7.3%
-20.0%£1.23B£453.90M2,063.112,000
BYIT
Bytes Technology Group
0.987 of 5 stars
GBX 491.80
+1.7%
GBX 642.67
+30.7%
+19.7%£1.18B£199.59M2,732.22930
KNOS
Kainos Group
2.1018 of 5 stars
GBX 940
+1.0%
GBX 1,280
+36.2%
-22.2%£1.18B£388.28M2,848.483,028
SPT
Spirent Communications
1.3322 of 5 stars
GBX 194.60
+1.5%
GBX 229.67
+18.0%
+9.9%£1.11B£474.30M6,486.671,656News Coverage

Related Companies and Tools

This page (LON:SXS) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners